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Signs and symptoms of saphenous nerve injury
after greater saphenous vein stripping: Prevalence,
severity, and relevance for modern practice
Charles Morrison, MD, and Michael C. Dalsing, MD, Indianapolis, Ind
Purpose: Saphenous nerve injury has long been recognized as a risk of greater saphenous vein stripping, and it has been
suggested by some authors as a reason to avoid stripping below the knee. The rate of injury reported in the literature is
extremely variable, with no study adequately addressing the effect of these injuries on patient quality of life. We
undertook this study to measure the prevalence of these injuries and quantify their impact on quality of life.
Methods: A cross-sectional study of patients who had undergone primary greater saphenous vein stripping to the ankle was
performed. Patients who had undergone this procedure, performed in a downward manner by a single surgeon over a
12-year period, were contacted and asked to return for a follow-up examination. Subjects completed the Aberdeen
Varicose Vein Symptom Severity Score as well as a questionnaire designed to identify symptoms of saphenous nerve injury
and any effects on quality of life. They were then evaluated for saphenous nerve deficits with simple neurologic tests.
Charts were reviewed to determine preoperative CEAP classification. Results were analyzed for statistically significant
differences between groups.
Results: Out of 111 patients (127 legs) who had undergone the procedure, 38 (34%) agreed to participate in the study.
Three of these patients were ultimately excluded because of an inability to obtain a reliable neurologic examination of the
legs, leaving 35 patients with a total of 45 legs operated. Participants did not differ from the potential study population
in demographic data, follow-up interval, or preoperative CEAP classification. Median time since operation was 4.5 years
(range, 8 months to 10.75 years). Overall, 40% of patients reported symptoms consistent with saphenous nerve injury at
some time after operation, but these symptoms affected quality of life in only 6.7%. Symptoms persisted at evaluation in
17.8%, and only one patient (2.3%) reported any negative effect on quality of life at the time of examination. Saphenous
nerve deficits were identified in 58% of patients. Patients with deficits had no statistically significant differences from those
without deficits in terms of demographic data, follow-up interval, preoperative CEAP class, or Aberdeen score.
Conclusions: Signs and symptoms of saphenous nerve injury are common at long-term follow-up after greater saphenous
vein stripping to the ankle. However, there appears to be little, if any, significant resultant morbidity. The risk of
saphenous nerve injury should therefore not be considered a reason to avoid stripping of the greater saphenous vein to the
ankle. (J Vasc Surg 2003;38:886-90.)
Saphenous nerve injury has long been recognized as a
potential complication of greater saphenous vein strip-
ping.1,2 Stripping of the vein in a downward fashion and
stripping that ends just below the knee have been reported
to decrease the risk of nerve injury, but they have not
eliminated the risk.2,3 Anatomic studies have identified
several reasons why these injuries may occur.4,5 The saphe-
nous nerve is located adjacent to the greater saphenous vein
throughout much of its course. This association is particu-
larly close from several centimeters below the knee to the
medial malleolus. The nerve has several sizeable branches
that cross directly over the vein. These branches are partic-
ularly vulnerable to avulsion during upward stripping as the
head used for the stripping procedure can engage and
disrupt them.5 Direct injury to the nerve can also occur
during dissection at the ankle or in the vicinity of the knee.
No study has directly addressed the effects of saphe-
nous nerve injury on patient quality of life. Despite this, the
risk of saphenous nerve injury is frequently cited as a reason
to avoid stripping of the greater saphenous vein below the
knee and as part of the arguments in favor of the use of
other techniques for treating greater saphenous vein in-
competence, such as high ligation and stab avulsion, inver-
sion stripping, radiofrequency ablation, and endovenous
laser ablation.3,6-8
Clinical problems with saphenous nerve injury have not
been evident at our institution, where we continue to
remove the entire greater saphenous vein if a venous duplex
evaluation, performed with the patient in the upright posi-
tion, confirms reflux to the ankle of greater than 1-second
duration in the presence of clinically apparent varicose
veins.9 This led us to suspect that the incidence of saphe-
nous nerve injury at our institution was much lower than
the literature would suggest or that the impact of these
injuries on patients was generally negligible. We therefore
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performed a cross-sectional study of patients who had
undergone high ligation and complete stripping of the
greater saphenous vein to determine the prevalence of
saphenous nerve deficits, the incidence of symptoms con-
sistent with saphenous nerve injury after surgery, and the
implications of these findings on the patients’ quality of life.
METHODS
Institutional review board approval was obtained from
the Indiana University Institutional Review Board. A pa-
tient database (Vascubase; Consensus Medical Systems,
Inc, Seattle, Wash) maintained by the Division of Vascular
Surgery at the Indiana University Medical School, India-
napolis, was queried to identify patients who had under-
gone high ligation and complete greater saphenous vein
stripping from groin to the ankle by a single surgeon
(M.C.D.) at any time in the previous 12 years. The opera-
tion is standardized for the surgeon. The vein is stripped in
two sections in a downward fashion, with the proximal
portion stripped from groin to two fingerbreadths below
the knee with a medium head on the disposal stripper
(Codman disposable vein stripper; Johnson & Johnson,
Codman and Shurtieff, Inc, Raynham, Mass). The distal
saphenous vein is stripped to the ankle in a downward
fashion with a small stripper head. Stab avulsion phlebec-
tomy is performed to remove prominent branch varicosities
in all cases. The patients’ charts were reviewed to determine
their preoperative CEAP classification. The patients were
then contacted by telephone and asked to participate in the
study. Those who agreed were interviewed and examined in
the outpatient vascular surgery clinic.
At the clinic visit, subjects completed the Aberdeen
Varicose Vein Symptom Severity Score (AVSS) question-
naire as well as a questionnaire designed specifically to
identify symptoms of saphenous nerve injury and any ef-
fects on quality of life (Fig 2, online only). The AVSS is a
validated disease-specific instrument for varicose veins.10
Patients were then evaluated for saphenous nerve deficits
with simple neurologic tests. A single examiner performed
all neurologic evaluations. Nociception was evaluated by
asking the patient to differentiate between sharp and dull
ends of a safety pin. Light touch was evaluated with the tip
of a small piece of gauze. Vibratory sensation was assessed
by placing a tuning fork on the bony prominences of the
leg. A complete sensory examination of both lower extrem-
ities from mid-thigh downward was undertaken even when
only one leg had undergone an operation. Any regions
demonstrating altered sensation (anesthesia, hypoesthesia
or dysesthesia) were recorded on a chart of the lower
extremities. The regions of sensory deficit were measured
with a small ruler, and the size of the affected region was
calculated as a rectangular area.
The AVSS was calculated for each patient (see Fig 2 for
details, online only). A qualitative assessment of the pa-
tients’ recall was made by reviewing the accuracy with
which they reported the year and side of the operation, as
well as their presenting symptoms. Our questionnaire was
reviewed for responses that indicated a saphenous nerve
injury that had at one time, or was currently having, a
negative impact on quality of life. We defined this as neu-
rologic symptoms attributable to the saphenous nerve caus-
ing moderate discomfort or limiting activities in any way.
Patients were considered to have saphenous nerve deficits if
they had measurable abnormalities in sensation within the
distribution of the saphenous nerve on the operated leg and
lacked abnormalities outside the distribution of the saphe-
nous nerve or in the contralateral leg (unless they had
bilateral procedures). Patients were considered to have had
a saphenous nerve injury if they had either symptoms (past
or present) consistent with nerve injury or a currently
identifiable saphenous nerve deficit. Recurrent varicose
veins were noted and tabulated.
Statistical analysis was performed with Sigma Stat
(SPSS Inc, Chicago, Ill). For purposes of calculation and
statistical analysis, each leg of the patients studied who had
bilateral procedures was considered as a separate individual.
Unpaired Student t tests or Mann-Whitney rank sum tests
were used as appropriate to compare numeric data, and 2
or Fisher exact tests were used for categorical data.
RESULTS
The database query yielded a total of 111 patients (127
legs) who had undergone high ligation and complete strip-
ping of the greater saphenous vein from groin to ankle in
the prescribed time period. Chart review identified no
patients with complications other than minor wound infec-
tions. Thirty-eight of these patients (34%) agreed to partic-
ipate in the study, and they were subsequently evaluated in
the outpatient clinic. Three of these patients were ulti-
mately excluded from the final analysis because of inability
to obtain an adequate neurologic examination. In one case,
this was because of severe diabetic neuropathy, which made
a neurologic examination less than reliable. In the other
two cases, the presence of substantial skin changes and
venous ulcerations related to a concomitant deep venous
insufficiency prohibited a reliable neurologic evaluation.
This left 35 patients with a total of 45 legs operated. There
were no statistically significant differences in terms of age,
gender, follow-up interval, or preoperative CEAP classifi-
cation between study participants and the total eligible
patient population (Table I).
The median age of study participants was 49 years
(range, 33 to 69 years). Median time since surgery was 4.5
years (range, 8 months to 10.75 years). Thirty-seven pa-
Table I. Comparison of eligible patients with study
participants
Eligible
patients
Study
participants P
Age (y) 49.1 50.6 .51
Gender (F/M) 74/37 20/13 .66
Preoperative CEAP 2.79 2.66 .60
Follow-up interval (y) 5.25 4.42 .29
CEAP clinical classification is listed.
JOURNAL OF VASCULAR SURGERY
Volume 38, Number 5 Morrison and Dalsing 887
tients (67%) were women, with a mean preoperative CEAP
clinical score of 2.67 (range, 2 to 6). Nine patients had
preoperative perforator incompetence, and five had deep
venous insufficiency as determined by venous duplex eval-
uation. The mean AVSS score was 10.3 at the time of the
study clinic visit. Six patients reported the incorrect year of
surgery, only two by greater than 1 year. All patients
accurately reported the side of surgery and their preopera-
tive complaints. Thirteen legs (29%) had recurrent varicos-
ities, generally presenting as isolated cluster varicosities.
Symptoms had not recurred at all in 27 legs (60%), and the
remainder had some recurrence of other symptoms (swell-
ing, pain) but no visible varicosities. No patient’s varicosi-
ties were sufficiently symptomatic or cosmetically displeas-
ing to cause them to seek a second surgical procedure for
recurrence.
Symptoms consistent with saphenous nerve injury at
some time after operation were reported in 18 legs (40%)
(Table II). Symptoms persisted at long-term evaluation in
eight legs (17.8%). Only three legs (6.7% of the study
population) ever met our criteria for a negative impact on
quality of life. At long-term evaluation, only one (2.3%)
continued to meet these criteria, and this patient was noted
to also have deep venous insufficiency in the common and
superficial femoral veins. For the 10 legs in which symp-
toms had resolved, those symptoms had a median duration
of 1 month (range, 1 day to 30 months). A shorter fol-
low-up interval in patients with a history of symptoms was
the only significant difference between these patients and
those without past or current symptoms (Table III).
Saphenous nerve deficits were documented by neuro-
logic examination in 26 legs (58%). The deficits covered a
median area of 50 cm2 (range, 25 to 300 cm2), and they
were concentrated in the vicinity of the medial malleolus
and the upper medial calf, just below the knee (Fig 1). Most
of these patients (14 of 26 legs, 54%) were unaware of any
area of diminished sensation before the study neurologic
examination, as documented by their failure to report any
neurologic symptoms at the time of the study. Of the 26
legs with deficits, a history of symptoms existed in 12, and
only 4 still had their symptoms at the time of the study.
There was a nonsignificant trend toward a shorter fol-
low-up interval in patients with deficits. There were no
statistically significant differences between patients with
deficits and those without (Table IV).
Thirty-two out of 45 legs (71%) had a history of saphe-
nous nerve symptoms, a documented deficit, or both.
Table II. Saphenous nerve symptoms reported by
patients
Symptom No. of legs (%)
Numbness 11 (24%)
Tingling 7 (15.5%)
Burning/shooting pain 6 (13.3%)
Total legs with symptoms 18 (40%)
Table III. Comparison of patients with past or present
saphenous nerve symptoms to those without
Nerve symptoms
(n  18)
No nerve symptoms
(n  27) P
Age (years) 48 50.6 .32
Gender (F/M) 11/7 19/8 .75
Preoperative CEAP 2.83 2.54 .36
AVSS 9.4 5.75 .42
Follow-up interval (y) 3.9 5.8 .03
Recurrent veins 5 8 .12
CEAP clinical classification is listed.
Fig 1. Schematic depicts location of deficits on the leg. In addi-
tion to the two areas shown, three legs (12%) had additional
deficits in other locations.
Table IV. Comparison of patients with and without
documented nerve deficits
Sensory deficit
(n  26)
No deficit
(n  19) P
Age (y) 49.8 49.3 .83
Gender (F/M) 15/11 15/4 .24
Preoperative CEAP 2.72 2.58 .65
AVSS 8.9 11.9 .32
Follow-up interval (y) 4.5 5.75 .12
Recurrent veins 8 5 .99
CEAP clinical classification is listed.
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Patients with deficits were not significantly different in
terms of age, preoperative CEAP class, postoperative AVSS
score, or presence of recurrent varicosities. Statistically sig-
nificant differences in patient gender and follow-up interval
were noted. Patients with deficits or symptoms were more
likely to be men, and they had a shorter follow-up interval
(Table V). However, male patients had a significantly
shorter follow-up interval than did female patients, 3.7
years versus 5.9 years (P  .005).
DISCUSSION
The prevalence in our study of saphenous nerve deficit
after high ligation and complete stripping of the greater
saphenous vein from the groin to the ankle correlates well
with the only randomized trial specifically designed to
explore this issue.3 Our findings, however, suggest that
these injuries are of little overall clinical importance, as they
have a negligible impact on the patients’ quality of life. The
patients did not experience significant discomfort or any
apparent disability. Symptoms of nerve injury were for the
most part transient and mild. Most patients with docu-
mented saphenous nerve deficits were completely symp-
tom-free, and many were completely unaware that a deficit
was even present before the neurologic examination per-
formed as a component of this study.
The area of the identified saphenous nerve deficit was
typically small, roughly 50 cm2. This deficit was most
commonly located in the vicinity of the medial malleolus,
with the second most common location on the medial calf
just below the knee. A portion of these deficits may have
been related to skin incisions and dissection used to place
the stripper, with resulting direct injury to the saphenous
nerve or a local cutaneous nerve. Others were not associ-
ated directly with these incisions, and they are therefore
likely caused by nerve branch avulsion or injury resulting
from tributary phlebectomy. Although direct injury caused
by dissection may explain many of the identified deficits,
the pattern of injury location is consistent with previously
described vulnerable nerve branches in the proximal calf
and near the medial malleolus. This suggests that although
downward stripping has been considered a method of
minimizing the risk of an avulsion injury, avulsion injury as
a potential origin of nerve injury in our study cannot be
ruled out.3-5
We hypothesize that the relatively asymptomatic nature
of the nerve injuries noted in this study may be caused, at
least in part, by our routine of performing the stripping
procedure in two stages. Removing the thigh portion of the
vein through the knee incision and switching to a small
stripper head for the below knee portion of the procedure
substantially reduces the bulk of the tissue that is pulled
through the leg and could potentially reduce the risk of
significant trauma to the nerve. We recommend this ap-
proach if complete greater saphenous vein stripping is
desired, as these potential benefits are obtained without any
substantial increase in the length or complexity of the
procedure.
Saphenous nerve injury has also been reported at a rate
of approximately 7% in stripping of the GSV to just below
the knee.3 We presume, on the basis of our operative
technique and what is known about the mechanism of
saphenous nerve injury, that the findings with regard to
quality of life would be similar if this study was carried out
in patients undergoing a vein stripping procedure terminat-
ing just below the knee.
In terms of overall efficacy as it relates to recurrence of
varicosities, our results are consistent with a recently re-
ported larger trial comparing stripping to the knee with
high ligation and stab avulsion that reported a 34% recur-
rence rate at 5 years in the patients undergoing the strip-
ping procedure.11 In the same study, 6% had undergone
upper leg reoperation for recurrent varicosities and 4% had
treatments for calf veins, and none of our patients found
reoperation a necessary avenue of care for their recurrent
varicosities. Interestingly, 29% of their patients had duplex-
confirmed reflux in the retained distal saphenous vein on
follow-up study and they expressed some concern that this
pathosis may eventually express itself as recurrent varicosi-
ties.
This study is limited by its size and retrospective, cross-
sectional nature. However, the absence of significant post-
operative complaints or complications on review of all
eligible patient charts suggests that our results do not
reflect a refusal of patients with significant injuries to par-
ticipate in the study, and we believe that on balance a recall
bias would tend to favor the reporting of more severe
symptoms over those that were less severe. The general
impression gained by this study and a review of the litera-
ture would suggest that the nerve is frequently affected
when stripping the greater saphenous vein. The clinical
effects may be minimal, on the basis of our findings.
In conclusion, the data presented in this study suggest
that although saphenous nerve deficits are common after
stripping of the greater saphenous vein to the ankle, they
have little clinical significance. Patients should be made
aware that sensory changes are likely after surgery, and that
although these changes may persist in a few patients, the
sensory deficits and other neurologic symptoms caused by
the operation are extremely unlikely to cause any apparent
clinical sequelae. Our data suggest that high ligation and
complete stripping of the greater saphenous veins accom-
plishes its primary purpose: The patients are generally sat-
Table V. Comparison of patients with nerve deficits and/
or nerve symptoms to those with neither deficits nor
symptoms
Symptoms or deficit
(n  32)
Neither
(n  13) P
Age (y) 49.75 49.15 .83
Gender (F/M) 18/14 12/1 .03
Preoperative CEAP 2.67 2.61 .84
AVSS 8.7 6.5 .36
Follow-up interval (y) 4.5 6.75 .014
Recurrent veins 9 4 1.0
CEAP clinical classification is listed.
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isfied with the results, and although recurrent varicosities
do occur, they are generally not sufficiently severe for
patients to seek further surgical intervention. The risk of
saphenous nerve injury after high ligation and complete
stripping of the greater saphenous vein should be under-
stood for what it is in a clinical sense and should not be a
major deterrent quoted to avoid conventional stripping in
favor of other techniques.
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Fig 2, online only. Questionnaire completed by study subjects. The first nine questions were developed specifically for
this study, and are aimed at identifying signs and symptoms of saphenous nerve injury and measuring their severity. The
remaining 13 questions compose the Aberdeen Varicose Vein Symptom Severity Score (AVSS), and are scored
separately from the first nine. The method of scoring the AVSS is described elsewhere.11
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